RxDoctor Payments Data

Alex Gonzalez, PA

Physician Assistant · Jupiter, FLNPI 1962884205

Payments from drug & device makers

$2,085in general payments, 2019–2025

Across 72 payments — averaging $28.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$383
  • Novartis$270
  • Johnson & Johnson$255
  • Boston Scientific$221
  • Amgen$197
  • E.r. Squibb & Sons, L.L.C.$188
  • plus $570 from 8 others

What the payments were for

  • Food & beverage$2,05098%
  • Education$362%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,085 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$63,993
Medicare patients
479
Services billed
674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban95$112,068
EntrestoSacubitril/Valsartan36$46,709
Repatha SureclickEvolocumab41$31,944
XareltoRivaroxaban15$19,859
Metoprolol Succinate123$2,150
Rosuvastatin Calcium96$1,868
Ranolazine ErRanolazine17$1,433
Amlodipine Besylate100$860
Nebivolol Hcl13$840
Losartan Potassium74$736
Midodrine Hcl15$674
Atorvastatin Calcium58$602
Digoxin17$590
Valsartan27$517
Diltiazem 24hr Er (Cd)Diltiazem Hcl25$488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$27$112,06895 claims
NovartisEntresto$270$46,70936 claims
Johnson & JohnsonXarelto$255$19,85915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Jupiter

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →